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Background: An emerging paradigm suggests children with autism display a unique pattern of environmental,
genetic, and epigenetic triggers that make them susceptible to developing dysfunctional heavy metal and chemical
detoxification systems. These abnormalities could be caused by alterations in the methylation, sulfation, and
metalloprotein pathways. This study sought to evaluate the physiological and behavioral effects of children with
autism sleeping in an International Organization for Standardization Class 5 cleanroom.
Methods: Ten children with autism, ages 3–12, slept in a cleanroom for two weeks to evaluate changes in toxin
levels, oxidative stress, immune dysregulation, and behavior. Before and after the children slept in the cleanroom,
samples of blood and hair and rating scale scores were obtained to assess these changes.
Results: Five children significantly lowered their concentration of oxidized glutathione, a biomarker of oxidative
stress. The younger cohort, age 5 and under, showed significantly greater mean decreases in two markers of
immune dysregulation, CD3% and CD4%, than the older cohort. Changes in serum magnesium, influencing
neuronal regulation, correlated negatively while changes in serum iron, affecting oxygenation of tissues, correlated
positively with age. Changes in serum benzene and PCB 28 concentrations showed significant negative correlations
with age. The younger children demonstrated significant improvements on behavioral rating scales compared to
the older children. In a younger pair of identical twins, one twin showed significantly greater improvements in 4
out of 5 markers of oxidative stress, which corresponded with better overall behavioral rating scale scores than the
other twin.
Conclusions: Younger children who slept in the cleanroom altered elemental levels, decreased immune dysregulation,
and improved behavioral rating scales, suggesting that their detoxification metabolism was briefly enhanced. The
older children displayed a worsening in behavioral rating scale performance, which may have been caused by
the mobilization of toxins from their tissues. The interpretation of this exploratory study is limited by lack of a
control group and small sample size. The changes in physiology and behavior noted suggest that performance of
larger, prospective controlled studies of exposure to nighttime or 24 hour cleanroom conditions for longer time
periods may be useful for understanding detoxification in children with autism.
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Children with autism spectrum disorders (ASDs) display
dysfunction in the areas of expressive language produc-
tion and quality, socialization ability, and control of ex-
cessive repetitive thoughts and behaviors [1]. Over the
past two decades, worldwide incidence and prevalence of
these disorders have increased; however, scholarly opinion
varies as to whether this rise is due to improved aware-
ness, better age-related screening efforts, higher quality
and quantity of diagnostic centers, an expansion of the
spectrum definition, the types of study methods used, or a
true escalation in the incidence and prevalence of autism
[2-8]. Although much research has focused on finding a
genetic cause of autism, it has not been successful in
explaining a majority of the diagnoses. In children with
ASDs, only 21% display genetic differences from the typic-
ally sequenced human DNA [9]. Copy number variants
and losses have been strongly associated with the develop-
ment of autism [10], potentially indicating a mechanism
for genetic/environmental interaction.
Effects of toxin exposure
A recent review noted the possible contributions of
toxin exposure during gestation and early childhood to
the development of autism [11]. Emerging literature on
the exposome, which measures environmental, extracel-
lular, and intracellular influences on the expression of
the genome, strongly suggests that adverse neurological
outcomes can be created by pre- and postnatal exposure
to toxins [12]. With the lack of success in finding a
purely genetic cause for autism, an emerging paradigm
suggests that one of the causes of the increased preva-
lence of ASDs could be difficulties in heavy metal and
chemical detoxification [13]. Multiple studies have previ-
ously correlated proximity to coal fired power plants,
pesticide-rich agricultural fields, known toxic chemical
sites, and traffic-related air pollution with the prevalence
of ASDs [14-18]. It has been hypothesized that difficul-
ties in detoxification can cause oxidative stress [19-23]
and immune dysregulation [24-28], leading to or exacer-
bating ASDs phenotypic presentation [29,30].
Exposure to environmental toxins, including heavy
metals and chemicals, have been shown to negatively
affect systems of detoxification involving glutathione
[31-33] and metallothionein [34,35], of which both zinc
and selenium are key cofactors [36]. Glutathione is the
central antioxidant responsible for environmental toxin
detoxification [37] and has been used as a biomarker of
oxidative stress to evaluate the methylation and sulfation
systems [38,39]. The metallothionein system is also ne-
cessary for heavy metal detoxification [40] and can be
assessed by the plasma zinc/serum copper ratio [35,41].
Studies have shown that total glutathione, reduced/oxi-
dized glutathione ratio, and zinc/copper ratio are oftenlower in children with ASDs [35,38,39,41]. Lower amounts
of total glutathione, triggered by increased environmental
toxin exposure, have been shown to also affect the im-
mune system of children with autism, as evidenced by
lower natural killer (NK) cell activity [42].
Difficulties in detoxification of heavy metals and che-
micals can lead to autoimmunity [43,44] and immune
dysregulation [24,25,27]. Forms of autoimmunity which
use NK cells to attack brain tissue [45] may contribute
to the under-connectivity between distant areas of the
brains of children with autism [46]. Certain markers of
immunological regulation and function [47-49], such as
the T cell helper/suppressor (CD4:CD8) ratio and CD4%
[50], are indicative of dysregulated innate and humoral
immunity [51]. Both the CD4:CD8 ratio and CD4% have
been shown to correlate with performance on the Aut-
ism Behavior Checklist [50], indicating a link between
immunological function and phenotypic presentation. In
addition, altered cytokine profiles in the immune sys-
tems of children with ASDs have been connected to be-
havioral instabilities [52]. Immune dysfunction has been
found in 15% to 60% of children with ASDs [53], and it
was recently shown that, when compared with controls,
children with ASDs exhibited greater evidence of in-
creased detoxification difficulties, oxidative stress, and
immune dysregulation [54].
Cleanrooms and detoxification
Given the emerging evidence connecting poor detoxifica-
tion of environmental toxins to the biomedical and clinical
presentation of ASDs, an intervention that temporarily de-
creases environmental exposure may positively impact
phenotypic presentation [55]. Concentrations of fine parti-
cles and gaseous chemicals can be reduced in cleanrooms
by using high efficiency particulate air (HEPA) filters and
activated carbon. Individuals who have spent time in a
cleanroom have presented reduced symptoms associated
with immunological response to IgE mediated allergies
and mold [56-58]. These unique allergic and immuno-
logical responses cause the release of mast cell media-
tors that can affect the central nervous system resulting
in detrimental behavioral effects in certain children
with autism [59].
The application of cleanroom technology in the treat-
ment of children with ASDs has been previously under-
taken [60-63]. These children improved significantly and
obviously in areas of expressive language, socialization,
and obsessiveness after the first several weeks of detoxi-
fication in their cleanrooms, and appeared to maintain
these gains even once removed from the clean environ-
ment [60-63]. It was discovered that children with
milder forms of autism appeared to improve when ex-
posed to lesser levels of environmental cleanliness, while
children with more severe autism needed to be fully
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be seen. These studies suggest that a cleanroom, which
reduces the burden on detoxification systems, may lead
to decreased oxidative stress and improved immuno-
logical and neurological functioning in children with
autism. Multiple studies have demonstrated the import-
ance of early treatment interventions [64-66]. It has been
shown that younger children, under age 6, with autism
display greater and more rapid response to intensive
treatments, and there may be a crucial time interval for
intervention before the end of early life developmental
plasticity [64].
This study sought to evaluate the effects of a clean-
room sleeping environment on toxin levels and markers
of oxidative stress, immune dysregulation, and behav-
ioral presentation in ten children with autism, 3 to
12 years of age. These effects were evaluated by quanti-
fying changes in blood toxin concentrations, glutathione
levels, and markers of immune function, and determin-
ing the correlation between age and improvement in
these markers.
Methods
After obtaining approval from the Institutional Review
Board (IRB) of Duquesne University (Pittsburgh, PA,
USA, IRB #09-131), the cleanroom was created and the
study was conducted at The Children’s Institute (TCI,
Pittsburgh, PA, USA). Before enrolling in the study,
consent was obtained from either a parent or legal
guardian, and a pictorial document explaining the study
was reviewed with each child.
Subject enrollment and study design
Ten children, ages 3–12, with autistic disorder confirmed
by a psychologist who is research certified to perform the
Autism Diagnostic Observation Schedule (ADOS) [67]
were recruited from the Neurodevelopmental Service of
TCI. Eligible children had to have prior evidence of heavy
metal and chemical toxicity and immune dysregulation
seen through low plasma zinc/serum copper ratios and
abnormal T and B cell subsets, respectively. Child #2 was
unable to participate in the study because of the inability
to complete a blood draw. The group intentionally con-
tained two sets of identical twins (ages 5 and 12). Children
were not eligible if they had severe behavioral dysregula-
tion, uncontrolled seizure activity, or any other severe
chronic medical condition, other than autism, that re-
quired frequent management by general pediatricians.
After signing the consent and being provided oppor-
tunity for child assent, each child and a parent spent
two consecutive weeks sleeping in the cleanroom be-
tween May and October 2010. During the day, the child
and parent went about their normal activities and ther-
apies. The child and parent arrived at TCI and spentapproximately ten hours each evening in the cleanroom
while wearing silk or cotton clothes. A research assist-
ant recorded each child’s sleep behaviors. The children
and family’s adjustment to the study was monitored by
a Family Advocate Psychologist who had no academic
involvement in the study. Diet, medications, nutrients,
and experiential services were held constant throughout
the study.Cleanroom design and classification
The cleanroom was designed and built at TCI in a modi-
fied hospital room. Cleanroom modifications were made
to the floors, walls, and ceiling tiles and the window was
encased in a secondary transparent enclosure. HEPA fil-
ters were mounted in each of the four air intakes in the
room. A Model 7512 Second Wind Air Purifier (Buffalo,
NY, USA) was placed in the room and set to the lowest
setting. The room was furnished with ash furniture
sealed with water soluble polyurethane from Stevens
Woodworks (Allison Park, PA, USA). The cleanroom
bedding was purchased from Naturepedic (Chagrin, OH,
USA). An ultraviolet water purification system was in-
stalled in the adjoining bathroom.
The cleanroom classification testing was performed using
a Hach (Loveland, CO, USA) Met One HHPC-6 Handheld
Airborne Particle Counter. Cleanroom classification
was performed following International Organization for
Standardization (ISO) standards using 0.5 μm particles [68].Blood draws, hair collection, and clinical testing
Within 24 hours before and after the two week period of
sleeping in the cleanroom, approximately 30 milliliters
of blood were drawn by a phlebotomist who specialized
in working with children with developmental disabilities.
The draws were completed at the child’s home and the
blood was processed and stored within two hours. The
blood was separated with a calibrated centrifuge and ali-
quoted for testing by Quest Diagnostics (Pittsburgh, PA,
USA) and Duquesne University. In addition, a hair sam-
ple was obtained from the back of the head, and it was
placed in a clean, sealable polyethylene bag for transport
to Duquesne University for analysis. The Quest Diagnos-
tics testing included plasma zinc; serum copper; T and B
lymphocyte subsets; serum IgA, IgG, and IgM immuno-
globulins; and complete blood count including differential
and platelets. The Duquesne University testing included
elemental analyses in serum, plasma, red blood cells
(RBCs), and hair; total, oxidized, and reduced glutathione
in RBCs; and benzene, toluene, and o-xylene along with
selected polychlorinated biphenyls (PCBs) in serum. Be-
fore analysis, the serum, plasma, and RBCs to be tested by
Duquesne University were stored at −80°C.
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Blood elemental analysis was conducted in serum,
plasma, and RBCs. For both before and after the clean-
room samples, two subsamples were prepared for each
matrix and child. Each 0.2 gram subsample was digested
with ARISTAR ULTRA nitric acid and ARISTAR
ULTRA hydrochloric acid in a Milestone Inc. (Shelton,
CT, USA) ETHOS 1 laboratory microwave system ac-
cording to EPA Method 3052 [69]. Samples were stored
in a cold room at 4°C until analysis. Total elemental ana-
lysis was performed according to EPA Method 6020B
[70]. An additional separate analysis was performed
using Isotope Dilution Mass Spectrometry (IDMS), a
component of EPA Method 6800 [71] for 9 selected ana-
lytes (antimony, cadmium, chromium, copper, lead, mer-
cury, molybdenum, selenium, and zinc) by spiking an
isotopically enriched mixture of each analyte into the
sample prior to microwave digestion. The analyses were
performed using an Agilent (Santa Clara, CA, USA)
7700 Inductively Coupled Plasma-Mass Spectrometer
operated in hydrogen, helium, and no gas modes. The
instrument was tuned in all three analysis-modes in
addition to determining the pulse/analog factor each day
before analysis. An Agilent internal standard solution
was used, and four replicates taken from each sub-
sample. The data was taken from Agilent MassHunter
software after analysis and exported into Microsoft Excel
for further data processing. Standard Reference Material
1598a (Inorganic Constituents in Animal Serum, National
Institute of Standards and Technology, Gaithersburg, MD,
USA) was used to validate the sample preparation and
analysis methods.
Hair elemental analysis was performed using EPA
Method 3052 microwave sample preparation and EPA
Method 6020B quantification. Sample preparation, ana-
lysis, storage, and quantification procedures followed
which were identical to the blood elemental analysis pro-
cedure, except for using 0.1 gram per subsample. Certi-
fied Reference Material GBW09101b (Shanghai, China),
Human Hair, was used as quality control for sample
preparation and analysis.
Organic toxin quantification
Organic compound quantification was performed on the
volatile organic compounds (VOCs) benzene, toluene,
and o-xylene using EPA Method 1624 [72] and selected
PCBs (PCB-28, PCB-52, PCB-101, PCB-138, PCB-153,
and PCB-180) using EPA Method 1625 [73]. Separate
analyses were completed for VOC and PCB quantifica-
tion, each requiring 200 μL of serum spiked with 2H la-
beled versions of each VOC or 13C labeled versions of
each PCB. Solid-phase microextraction was performed
on the headspace of the samples using a polydimethylsi-
loxane/divinylbenzene fiber for VOCs and polyacrylatefiber for the PCBs. An automated Gerstel (Linthicum,
MD, USA) MultiPurpose Sampler II and Agilent 7890A
Gas Chromatography and an Agilent 5975c quadrupole
Mass Spectrometer were used for sample analysis and
Agilent Chemstation for data analysis. Three independ-
ent samples were prepared for each sample, both before
and after the cleanroom, with one analysis performed
on each.
Glutathione
The blood used for glutathione analysis was transported
to Duquesne University on ice and shielded from light.
The samples were aliquoted in an inert nitrogen atmos-
phere and then centrifuged at 2,000 relative centrifugal
force (RCF) at 4°C for 15 minutes. The separated RBCs
were aliquoted under inert atmosphere conditions and
placed into a −80°C freezer for storage.
For total glutathione (tGSH) analysis, 30 milligrams
(mg) of RBCs were combined with a known amount of
enriched GSH and 300 mgs of approximately 10,000
microgram gram−1 (μg g−1) dithiothreitol for 20 minutes.
Each sample was then treated with 1 mL of acetonitrile
(ACN) to precipitate out the proteins, and the sample
was centrifuged at 4°C at 5,000 RCF. The resulting
supernatant was analyzed using an Agilent 6460 Liquid
Chromatography-Tandem Mass Spectrometer (LC-MS/
MS). Sample preparation was performed in triplicate
and analyses done in duplicate. Quantitation was per-
formed using IDMS as described in EPA Method 6800.
For reduced (GSH) and oxidized (GSSG) glutathione
analysis, known masses of RBC samples were treated with
approximately 8,000 μg g−1 N-ethylmaleimide in an inert
atmosphere environment while thawing. Each sample was
then spiked with known amounts of enriched GSH and
GSSG and equilibrated for approximately 30 minutes. The
proteins were precipitated out of the samples by adding
1 mL ACN, and then centrifuged at 4°C at 5,000 RCF for
3 minutes. The resulting supernatant was evaporated off
under vacuum, and the residue was redissolved in 40 mi-
croliters (μL) of water after the addition of 120 μL of ACN
for LC-MS/MS analysis. Sample preparation was per-
formed in triplicate with analysis in duplicate. Quantita-
tion was performed using Speciated Isotope Dilution
Mass Spectrometry (SIDMS), the other component of
EPA Method 6800 [71], that corrected for the interconver-
sion of the glutathione species.
Behavioral rating scales
The same parent filled out multiple behavioral rating
scales within 24 hours of the beginning and end of the
cleanroom experience. The rating scales completed in-
cluded the Social Communication Questionnaire (SCQ)
[74], PDD Behavioral Inventory (PDDBI) [75], Aberrant
Behavior Checklist (ABC) [76], Gilliam Autism Rating
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Checklist (ATEC) [78], and Childhood Autism Rating
Scale (CARS) [79]. The SCQ is used to assess the social
interactions, language and communication aptitude, and
stereotyped and repetitive behaviors of children with an
autism spectrum disorder [80]. The PDDBI has multiple
domains and composites that measure both adaptive
and maladaptive behaviors [81], and the Autism Com-
posite is calculated using selected domains. The total
ABC is the summation of five subscales: (I) Irritability,
Agitation, Crying; (II) Lethargy, Social Withdrawal; (III)
Stereotypic Behavior; (IV) Hyperactivity, Noncompli-
ance; and (V) Inappropriate Speech [76]. The results of
these rating scales were recorded and pooled for statis-
tical analysis.Statistical analyses
All statistical analyses were performed using the R statis-
tical software package. To investigate an overall clean-
room impact, the n = 10 pre-cleanroom measurements
were subtracted from the corresponding post-cleanroom
measurements for each variable. Paired t-tests were used
to identify whether the observed mean differences devi-
ated significantly from zero. Two separate statistical ana-
lyses were performed to investigate the relationship
between measurement change and subject age. Prelimin-
ary statistical analysis indicated the necessity to divide
the entire study population into younger and older co-
horts. An independent sample t-test was implemented
for each variable to assess whether the average difference
observed for subjects in the younger cohort, age 5 and
under, was significantly different than for subjects in the
older cohort, who were age 6 and older. A Pearson cor-
relation between measurement difference and subject
age was also computed for each variable.
Replicate analyses were performed for all chemical and
elemental tests, allowing for confidence intervals to be
used as a means of comparing difference in values. The
rating scale and commercial laboratory measurements
are single-measurement results and do not provide such
statistical power. An independent samples t-test was used
to determine whether the average of the pre-cleanroom
replicate measurements for a particular subject differed sig-
nificantly from the average of the post-cleanroom replicate
measurements for that subject. The fact that funding con-
straints allowed for only n = 10 subjects is the greatest stat-
istical limitation of this study. This sample size provided
relatively weak statistical power (as compared to larger
sample sizes) for recognizing small or moderate differences
when they exist. This issue, combined with the exploratory
nature of this study and the fact that variables within a cat-
egory are often correlated (as with the rating scale vari-




The measurements taken during the study showed that
the cleanroom met criteria for an ISO Class 5 classifica-
tion with an average of 1,292 particles 0.5 μm m−3. Both
the average of the five sampling locations and 95% upper
confidence interval (CI) bound for a one sided t-test were
below the ISO Class 5 limit of 3,520 particles 0.5 μm m−3.
In comparison to an unmodified, adjacent room, the
cleanroom had a 175 fold decrease in the number of
0.5 μm particles.
Markers of environmental toxin exposure
Elemental analysis of blood and hair
Significant results were observed when two types of age
analyses were performed (Figures 1 and 2). Significant
negative correlation with age was found for changes in
serum magnesium (p = 0.047, r = − 0.64). Conversely,
significant positive correlation with age was found for
changes in serum iron (p = 0.050, r = 0.63). The changes
in RBC selenium were nearly significantly positively cor-
related with age (p = 0.051, r = 0.63). Additional statis-
tical analysis on the age based cohorts indicated that the
younger children, ages 5 and under, decreased both their
RBC selenium (p = 0.011) and RBC zinc (p = 0.028) to a
greater degree on average when compared to the older
children, age 6 and older.
No significant changes or age correlations were ob-
served for hair elemental concentrations. It was noted
that each of the children had a unique profile of heavy
metals in their hair as they displayed varying concentra-
tions of aluminum, antimony, arsenic, cadmium, chro-
mium, lead, manganese, mercury, nickel, and tin in their
hair before beginning the study [82].
Analysis of organic toxins
Detectable quantities of benzene, toluene, and o-xylene
were found in all serum samples at, or exceeding, national
averages [83]. The change in serum benzene concentra-
tion negatively correlated with age (p = 0.021, r = − 0.71)
as seen in Figure 3. One child in the older cohort signifi-
cantly increased toluene by independent samples t-test.
One child demonstrated a significant drop in o-xylene
concentration by independent samples t-test. There
were no significant differences in VOC concentrations
in paired t-tests of pre- and post- findings for the set of
ten children.
In every sample in which PCB 28, PCB 52, PCB 101,
and PCB 138 exceeded the quantification limit, the
serum concentration was greater than the national aver-
age for 12–19 year old children [83]. The change in
Figure 1 Changes in serum magnesium, serum iron, and RBC selenium versus age. Younger children had a greater tendency to raise their
serum magnesium than older children as it was negatively correlated with age (p = 0.047). There was a significant positive correlation between
the change in iron and age (p = 0.050). There was a near significant positive correlation between age and change in RBC selenium concentration
(p = 0.051). There are two points at 0 for age 12 for the serum iron change.
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r = − 0.72) as seen in Figure 3. Two children increased
PCB 28 concentrations significantly. The concentrations
of PCB 52 decreased significantly in two children and in-
creased significantly in two others by independent samples
t-tests. No statistically significant changes or correlations
were observed when PCB 101 and PCB 138 were detected
and quantified, and PCB 101 was detected at the highest
average concentration of all of the PCBs measured. In
addition, PCBs 153 and 180 were not quantifiable in any
of the ten children. There were no significant differences
in PCB concentrations in paired t-tests of pre- and post-
findings for the entire cohort. Overall, changes in serumFigure 2 Elemental analysis results in RBCs for zinc and selenium. When
from the older six children, significant decreases were seen for RBC seleniumbenzene and PCB 28 concentrations showed significant
negative correlations with age, with the younger chil-
dren showing the greatest post-cleanroom increase in
concentration.
Markers of oxidative stress
The glutathione results are shown in Table 1. Five chil-
dren significantly decreased their GSSG after the clean-
room by independent samples t-test (Figure 4), four
from the older cohort and one from the younger. This
younger child also significantly increased GSH, reduced
glutathione/oxidized glutathione ratio (GSH/GSSG), and
total glutathione/oxidized glutathione (tGSH/GSSG) byapplying a cutoff at age 5 which separated the younger four children
(p = 0.011) and RBC zinc (p = 0.028) in the younger cohort.
Figure 3 The results of the differences for benzene and PCB-28 versus age. The results display a negative correlation with age for each
chemical with p = 0.021 for benzene and p = 0.028 for PCB-28.
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tGSH/GSSG was seen in three children, one younger and
two older, along with a significant decrease in tGSH/
GSSG ratio in one older child. All ten children displayed
the same overall pattern- an increase, even if not statisti-
cally significant, of GSH/GSSG was accompanied by a de-
crease of GSSG or vice versa. No significant differences
were observed using paired t-tests comparing pre-and
post-measurements of glutathione species of the entire
group. In all, five children improved significantly in atTable 1 The before and after red blood cell glutathione results
GSH (μmol g−1) GSSG (μmol g−1)
Child 1 Before 2.06 ± 0.95 0.0970 ± 0.0051
Child 1 After 1.87 ± 0.28 0.0802 ± 0.0022
Child 3 Before 1.53 ± 0.39 0.0693 ± 0.0022
Child 3 After 1.00 ± 0.06 0.0354 ± 0.0007
Child 4 Before 1.58 ± 0.04 0.0485 ± 0.0009
Child 4 After 1.81 ± 0.19 0.0453 ± 0.0025
Child 5 Before 1.83 ± 0.71 0.0707 ± 0.0028
Child 5 After 1.77 ± 0.49 0.0454 ± 0.0128
Child 6 Before 1.70 ± 0.21 0.0577 ± 0.0032
Child 6 After 2.32 ± 0.28 0.0425 ± 0.0049
Child 7 Before 2.25 ± 1.22 0.0189 ± 0.0025
Child 7 After 2.32 ± 1.42 0.0177 ± 0.0030
Child 8 Before 2.35 ± 1.08 0.0290 ± 0.0050
Child 8 After 2.06 ± 0.49 0.0379 ± 0.0058
Child 9 Before 1.72 ± 0.16 0.0489 ± 0.0076
Child 9 After 1.69 ± 0.17 0.0424 ± 0.0016
Child 10 Before 2.08 ± 0.38 0.0156 ± 0.0009
Child 10 After 1.82 ± 0.14 0.0278 ± 0.0026
Child 11 Before 2.39 ± 0.62 0.0111 ± 0.0014
Child 11 After 2.07 ± 0.29 0.0289 ± 0.0048
The bolded values denote significant difference by independent samples t-tests. Chleast one marker of oxidative stress, with one belonging to
the younger cohort.
Markers of immune dysregulation
Significant clinical results for several markers of immune
regulation are summarized in Table 2. When separated
into cohorts, the younger children significantly de-
creased their CD3% (p = 0.036) and CD4% (p = 0.028)
compared to the older children. Total white blood cell
(WBC) count significantly increased in the younger(μmol g−1) according to EPA Method 6800 (n = 6, 95% CIs)
GSH/GSSG tGSH (μmol g−1) tGSH/GSSG
21.1 ± 9.0 2.45 ± 0.32 25.3 ± 4.2
23.4 ± 3.9 2.39 ± 0.20 29.8 ± 2.8
22.3 ± 6.4 2.01 ± 0.21 29.0 ± 2.9
28.3 ± 1.9 2.11 ± 0.23 59.6 ± 6.5
32.6 ± 0.4 2.11 ± 0.13 43.4 ± 3.1
40.1 ± 5.4 2.28 ± 0.21 50.3 ± 4.2
25.9 ± 10.1 2.07 ± 0.29 29.3 ± 4.2
39.1 ± 3.4 2.07 ± 0.23 47.7 ± 11.0
29.5 ± 3.5 2.35 ± 0.29 40.8 ± 5.4
54.7 ± 4.8 2.36 ± 0.26 55.8 ± 6.0
127 ± 85 2.13 ± 0.20 113 ± 6
139 ± 96 2.18 ± 0.18 126 ± 24
86.3 ± 49.4 2.21 ± 0.38 76.6 ± 10.4
57.1 ± 24.2 2.25 ± 0.36 61.3 ± 18.0
36.0 ± 7.3 1.88 ± 0.16 39.3 ± 8.4
40.0 ± 4.9 1.86 ± 0.16 44.1 ± 5.3
134 ± 28 2.75 ± 1.44 179 ± 100
66.1 ± 9.4 2.26 ± 0.55 81.8 ± 20.9
221 ± 71 2.35 ± 0.42 217 ± 58.5
73.9 ± 21.0 2.34 ± 0.31 83.7 ± 23.2
ild 2 was unable to participate in the study.
Figure 4 The before and after results for RBC oxidized
glutathione for the ten children (n = 6, 95% CIs). Seven of the
ten children decreased their mean red blood cell oxidized
glutathione concentrations, with five of these decreases significant
by independent samples t-test. Child #2 was unable to participate in
the study.
Faber et al. BMC Complementary and Alternative Medicine  (2015) 15:71 Page 8 of 15children and decreased in the older children (p = 0.031).
The younger cohort tended to increase their IgA levels,
while the older cohort tended to lower their IgA levels
(p = 0.059). The clinical laboratory plasma zinc/serum
copper ratio exhibited a tendency to increase in the
older six children compared to the four younger children
(p = 0.061). The results for these markers of immune
dysregulation for the two cohorts are shown in Figure 5.
Behavioral rating scales
The before and after cleanroom rating scale results for all
10 children are summarized in Table 3 with significant
correlation coefficients (r) and p-values listed in Table 4.
The younger cohort demonstrated significant decreases in
SCQ means (p = 0.025). The changes in SCQ versus age
were also significant, with a positive correlation (r =
0.68, p = 0.030) seen in Figure 6. Additional positive
correlations with age were found in the changes in Aut-
ism Composite of the PDDBI (r = 0.64, p = 0.046) and
the Sensory/Perceptual Approach Behaviors (SENSORY)
subscale of the PDDBI (r = 0.64, p = 0.045). The Recep-
tive/Expressive Social Communication Abilities Compos-
ite (REXSCA/C) showed significant negative correlations
with age (r = −0.66, p = 0.037), which indicates languageTable 2 Statistically significant changes and trends in the
commercial laboratory results of mean differences
between age groups when a cutoff is applied separating








CD3% −2.75 2.33 0.036
CD4% −2.50 1.67 0.028
WBC 2.13 −0.70 0.031
IgA 4.25 −13.17 0.059
Zinc/Copper Ratio −0.08 0.13 0.061improvement in the younger cohort. None of the other
domains or composites of the PDDBI produced significant
results. The change in the total ABC by age of the ten
children was nearly statistically significant with a p-value
of 0.054 (r = 0.62). Furthermore, three of the five subscales
of the ABC were significantly positively correlated with
age (p = 0.034 for subscale III, p = 0.024 for subscale
IV, and p = 0.035 for subscale V). The two remaining
subscales of ABC showed no significant correlations.
There were no significant differences in rating scales
results in the paired t-test analyses of pre- and post- re-
sults. The GARS-2, ATEC, and CARS produced no sta-
tistically significant results for change or age correlation.
In total, six scales, subscales, domains, or composites
used as markers of ASD behavioral presentation agreed
in finding a statistically significant correlation with age
between pre-and post-cleanroom ratings. Of note, each
of the four younger children improved on the SCQ scale.
Of these four, two raised their GSH/GSSG ratio, with
one significant by independent samples t-test.
Twins
The study contained two sets of identical twins, one
younger and one older set. Children 6 and 8 were five-
year-old females. Child 6 significantly improved on four
out of five markers of oxidative stress seen in Table 1
(GSH, GSSG, GSH/GSSG, and tGSH/GSSG). This im-
provement in oxidative stress was mirrored by a better
performance in the rating scales SCQ and PDDBI; the
subscales ATEC I, ATEC II, ABC I, ABC II, ABC V;
GARS-2 Communication, Social Interaction, and Autism
Index; and all of the maladaptive domains and compos-
ites and the Autism Composite of the PDDBI (Table 3).
The corresponding twin, Child 8, did not improve on
any markers of oxidative stress and, likewise, did not im-
prove performance on rating scales, subscales, compos-
ites, and indexes.
Children 3 and 4 were twelve-year-old male identical
twins. Both children raised their GSH/GSSG, with Child
4 showing greater improvement. This disparity in im-
provement was mirrored in better performance for Child
4 on many rating scales, subscales, and composites.
Child 4 demonstrated better performance on the PDDBI,
CARS, and SCQ; ATEC total and subscales; ABC total,
I, and IV; Communication subscale of GARS-2; and the
SENSORY, Social Pragmatic Problems, Semantic/Prag-
matic Problems, Arousal Regulation Problems, Specific
Fears, Aggressiveness, Social Approach Behavior do-
mains along with the Repetitive, Ritualistic, and Prag-
matic Problem Behaviors, Approach/Withdrawal, and
Autism Composites of the PDDBI [82]. In both sets of
identical twins, the child with the larger improvement in
markers of oxidative stress showed the greater improve-
ment in behavioral rating scales following the study.
Figure 5 Results of the clinical laboratory differences for CD3%, CD4%, WBCs, IgA, and zinc/copper ratio. When applying a cutoff at age 5,
separating the younger four children from the older six children, significant decreases were seen for CD3% (p = 0.036) and CD4% (p = 0.028), and a
significant increase was seen for WBC (p = 0.031). Trends for increased IgA (p = 0.059) in the younger cohort and elevated zinc/copper ratios (p = 0.061)
in the older cohort were present. For CD3% change, two points overlap at +2 in the older cohort. For CD4% change, two points overlap at both – 1
and +1 in the older cohort. In the older cohort for IgA change, two points overlap at – 15.








Total ABC Total ATEC CARS Autism index
(GARS-2)
Before Before After Before After Before After Before After Before After Before After
1 6 17 22 24 57 54 38 34 51 60 36 34 85 91
3 12 13 20 27 76 84 92 118 85 96 47 49.5 119 126
4 12 15 28 30 73 75 69 91 101 96 46.5 48 106 117
5 11 14 25 24 61 59 65 50 59 44 40 43 100 103
6 5 14 27 20 50 44 12 13 62 58 34 36.5 79 74
7 8 16 30 30 65 66 116 128 95 108 51 50.5 112 115
8 5 12 21 20 45 47 13 14 55 54 33.5 33 64 81
9 4 16 23 14 41 39 57 27 55 57 39 26.5 82 64
10 3 17 26 23 57 53 64 42 52 59 39 38 94 87
11 12 14 13 13 41 42 5 3 51 49 21 22 76 85
Child 2 was unable to participate in the study. Children 3 and 4 and children 6 and 8 were identical twins.
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Table 4 Statistically significant difference correlations
comparing child age and difference in rating scale scores
Rating scale r p-value
SCQ 0.68 0.030
PDDBI Autism composite 0.64 0.046
Total ABC 0.62 0.054
ABC III 0.67 0.034
ABC IV 0.70 0.024
ABC V 0.67 0.035
PDDBI REXSCA/C −0.66 0.037
PDDBI SENSORY 0.64 0.045
The correlations and p-values are shown for each significant variable.
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During this study ten children with ADOS certified aut-
ism slept in a hospital cleanroom for a two week period.
The cleanroom maintained ISO Class 5 certification,
which minimized the nighttime exposure of both chil-
dren and parents to heavy metals and VOCs. Given the
emergent data linking exposure to environmental toxins
with autism etiology, experiencing a cleanroom environ-
ment during sleep was hypothesized to begin the process
of detoxification by mobilizing heavy metals and chemi-
cals into the blood and hair.
Five children significantly lowered their GSSG concen-
trations in RBCs, the component of blood with the highest
glutathione concentration [84]. The decrease in GSSG
concentrations could indicate a reduction of oxidative
stress, suggesting an increased ability to eliminate inflam-
mation, prevent infections, and detoxify environmentalFigure 6 Differences for the SCQ, Autism Composite of PDDBI, and to
near significance for each rating scale with a p-value of 0.030 for SCQ, 0.04
age 5 with a difference of +1 for total ABC.toxins [39]. Three children raised their tGSH/GSSG ratio,
an improvement in an indicator of the balance of glutathi-
one species [38], which was driven by a decrease in GSSG.
In all ten children, an inverse relationship was observed
between the change in glutathione ratios, tGSH/GSSG
and GSH/GSSG, and the change in GSSG concentration.
High GSH/GSSG ratios preserve the necessary reducing
environment inside of cells [85]; abnormally low GSH/
GSSG ratios may indicate an inadequacy of glutathione re-
ductase [39]. Numerous studies have noted the multiple
functions regulated by the redox balance of GSH/GSSG
[33,39,86]. Decreases in GSSG may have been the result of
improved transulfuration reducing the demand for adeno-
sine [38], the nucleoside that prevents oxidative damage
[87,88].
The younger cohort showed significantly greater de-
creases in RBC zinc and selenium concentrations than
the older cohort. The younger children may have moved
selenium and zinc more rapidly from red blood cells to
tissues, increasing metalloprotein functioning more than
the older children. In addition, serum magnesium changes
were significantly negatively correlated with age, increas-
ing in concentration in the younger children. Magnesium
is a critical micronutrient that is essential in the mainten-
ance of the calcium/magnesium flow across neuronal cell
membranes [89]. It also plays a key role in enzymes re-
lated to ATP and nucleic acid metabolism [90]. Proper
brain development and homeostasis require magnesium
resulting from copper-zinc superoxide dismutase activity
[91]. When given as a supplement, magnesium has been
shown to have a calming effect on the behavior of childrental ABC rating scales versus age. The results display significance or
6 for Autism Composite, and 0.054 for total ABC. Two points overlap at
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creased serum concentrations and improved behavioral
presentations observed in this study. Additionally, iron
concentration changes correlated positively with age. The
younger children decreased and the older children in-
creased their respective concentrations. Iron is critical for
erythrocyte production and the promotion of oxygenation
of tissues; its effects on metabolism depend on local con-
centration [94]. At higher levels, though, iron can cause
an excessive production of reactive oxygen species, digest-
ive problems, vomiting, and the alteration of other closely
related elements such as zinc, copper, and calcium [95].
The observed positive age correlation in serum iron may
be explained by a faster upregulation in the metallothio-
nein system of the younger children. This upregulation
would lead to an increased need for erythrocyte produc-
tion to enhance oxygen distribution to tissues, depleting
serum iron. Hair selenium concentrations tended to cor-
relate negatively with age. The younger children had either
increases or small decreases in their hair selenium con-
centrations compared to the older ones. The increased re-
lease of selenium in the hair in the younger children may
have been secondary to increased absorption of selenium.
Significant changes in hair concentrations of elements
may have required a longer period of exposure to clean-
room conditions.
Prior to exposure to the cleanroom, VOCs and PCBs
were quantified at concentrations above the national av-
erages for adolescents [83] in many of the children. Out
of the ten participants, eight decreased mean serum ben-
zene, six increased mean serum toluene and five in-
creased serum xylene, although none significantly. One
possible explanation for these results is that, throughout
the study, VOCs were mobilized from tissues into the
serum at varying rates. In this scenario, benzene would
be mobilized and released from the body first, leading to
decreased serum concentrations. Toluene and o-xylene,
however, could require more time to mobilize and result
in the tendency for increased serum concentrations fol-
lowing the two week exposure to the cleanroom. Like-
wise, mean PCB-28 concentrations rose in six out of
seven children, which significantly negatively correlated
with age, with three children falling below the analytical
quantification limit. This result is consistent with the hy-
pothesis of the cleanroom beginning the process of
mobilization of PCB-28 from tissue to serum, but re-
quiring more time for elimination from the serum.
Following exposure to the cleanroom environment, the
children demonstrated changes in markers of immune
system functioning. These changes indicate a decrease of
T cell subtypes instructing B cells to make antibodies.
Notably, the younger children decreased CD3% (total T
cell percent) and CD4% (total helper T cell percent) sig-
nificantly more than the older cohort. This data providesevidence that the cleanroom may have decreased dysregu-
lation of the immune system, especially in the younger
children. B cells promote immunoglobulin synthesis
and are regulated by CD4 cells. The observed decrease
in CD4% may have lessened cross reactive antibody
production in the younger children, leading to a brief
period of decreased brain inflammation. This is one
possible explanation of the significant, but transient,
improvement seen in the behavioral rating scale perfor-
mances of the younger cohort.
Significant changes in before and after cleanroom re-
sults were seen for rating scale performance when com-
pared with age. Specifically, the younger children in the
study tended to improve on the behavioral rating scales
SCQ, sub-domains of the PDDBI, and ABC while the
older children tended to do slightly worse on these rat-
ing scales. The PDDBI was created specifically to evalu-
ate how children with pervasive developmental disorders
respond to a treatment, with the unique capability to
standardize results by age [81]. In contrast with other
scales and indices, the PDDBI assesses both adaptive and
maladaptive behaviors, giving a quantitative definition to
positive improvements. A significant age-correlation was
noted in the Autism Composite of the PDDBI, with the
younger children showing greater improvements in non-
verbal communication, repetitive behaviors, social inter-
action, and spoken language. The SENSORY domain of
the PDDBI produced a significant negative correlation
with age indicating more improvement of nonverbal
communication in the younger children compared to
the older children. The negative correlation with age on
the REXSCA/C demonstrates significantly more im-
provement in receptive and expressive language attain-
ment in the younger children compared to the older
children. The improvements on the total ABC, designed
to assess treatments for individuals with intellectual dis-
abilities [76], were primarily driven by the significant im-
provements on the stereotypical behavior, hyperactivity,
and speech subscales. One possible explanation of these
rating scale results is that the younger children may have
had less of an initial body burden of heavy metals and
chemical toxicants, allowing the brief two week period of
sleeping in the cleanroom to have a slightly more positive
behavioral effect. The older children, who may have had a
larger body burden of toxicants initially, may have just
begun the process of mobilization of chemicals and metals
as the study ended, resulting in worse behavioral result
changes in relation to the younger children. Younger chil-
dren may have felt an extra closeness to their parents dur-
ing the study, leading to positive behavioral change. The
interpretation of this study is limited by the small sam-
ple size, lack of Bonferroni correction for multiple com-
parisons, and absence of a control group. However,
age-correlated findings involving changes in elemental,
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study provide support for physiological change driving
the behavioral improvements in the younger children.
One of the unique results of this study involved the re-
sponses of two sets of identical twins and the manner in
which changes in glutathione species corresponded with
behavioral rating scale results. In both sets, one twin
demonstrated greater improvement in oxidative stress,
as evidenced by glutathione markers, and corresponding
greater improvement in behavioral rating scale scores.
The GSH/GSSG ratio is a critical biomarker for deter-
mining healthy functioning of the methylation system in
children with autism [96]. In the 5-year-old female iden-
tical twin pair, the twin who raised her GSH/GSSG ratio
also performed better on two behavioral rating scales,
the SCQ and PDDBI. Notably, this female twin displayed
the greatest improvement of oxidative stress in the study,
significantly lowering GSSG and increasing GSH, tGSH/
GSSG, and GSH/GSSG values. In the older male identical
twin pair, both children worsened on the behavioral scales,
but the twin with greater GSH/GSSG ratio improvement
displayed less worsening on the SCQ and PDDBI. Despite
identical home settings and genomes, it was found in both
sets that each twin responded uniquely to sleeping in the
cleanroom, displaying varying degrees of change in GSH/
GSSG levels and behavioral rating scale performance.
These differences suggest that still unknown epigenetic
mechanisms mediated the varying results between the
twins in the study. This study provides further support
to the assertion of a relationship between glutathione
biomarkers and behavioral rating scores in children
with autism.
Conclusions
In this study, ten children with ADOS certified autism
spent two weeks sleeping in a cleanroom. The overall pat-
tern of results indicates greater improvements in immune
dysregulation and behavior in the younger children, age 5
and under. Half of the children significantly decreased
their oxidative glutathione concentrations in addition to
improving other glutathione markers of oxidative stress.
The relationship between GSH/GSSG and the identical
twins’ behavioral performances, the opposite movements
of serum iron and magnesium compared to age, and the
tendency for the younger children to reduce their CD3%
and CD4% all suggest the possibility of a significant
physiological role for the cleanroom in explaining some of
the behavioral changes. Younger children performed bet-
ter on rating scales after their two week exposure, while
the older children performed slightly worse on rating
scales. Psychological issues, such as greater attachment to-
wards the parent in the cleanroom, may explain some of
this difference; however, the noted biological differences
in how the younger children performed versus olderchildren suggest that the cleanroom may have had a more
than psychological effect. The children only slept or stayed
for approximately ten hours a night in a cleanroom for
two weeks; yet, significant changes in markers of oxidative
stress, immune dysregulation, and behavior were ob-
served. In addition, an age correlated difference in detoxi-
fication physiology is suggested by the results. At the age
of 6, a significant difference tended to occur in the direc-
tion of change for some elemental nutrients (iron, magne-
sium, selenium, and zinc), organic toxicants (benzene and
PCB 28), and immune markers (CD3% and CD4%). The
younger children may have started their detoxification
process faster or had less to detoxify, thus explaining their
significant improvement in global rating scales (SCQ,
PDDBI, and ABC) compared with the older children. The
differential response to the cleanroom by the identical
twins suggests that epigenetic changes may be playing a
role in affecting responses to a detoxifying environment.
Interpretation of this prospective cohort study is limited
by the lack of a control group and small sample size. The
exploratory nature of the study supported not performing
Bonferroni correction and the use of a p value of 0.05 for
significance. The performance of a controlled study of
24 hour per day cleanroom exposure for children with
autism appears to be an appropriate next step, given the
physiologic changes from the limited exposure to a clean-
room environment noted in this study.
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